supports insulin sensitivity Nervous System: Protects against neurodegeneration and cognitive decline Skin: Improves autoimmune conditions and accelerates wound healing Future Applications of GLP-1 Medications As clinical trials continue, GLP-1 receptor agonists may soon be approved for: Neurodegenerative diseases: Alzheimers, Parkinsons, MS Autoimmune conditions: Psoriasis, RA, Lupus Cardiometabolic syndromes: NAFLD, PCOS, atherosclerosis Pulmonary conditions: Chronic bronchitis, COPD, even long-COVID inflammation Final Thoughts GLP-1 medications are no longer just diabetes or weight loss drugs
doi: 10.1038/s41591-024-03183-4 477 ZhaiB.RollingT.HohlT
Normal thyroid function can be affected by these epigenetic modifications and supports the immune systems defense against thyroid antigens
Working with a healthcare professional to develop a personalized monitoring plan is highly recommended
Here is a simple treatment roadmap for you to follow for your patients: As you can see, you begin by prescribing 0.5 mg/mL Sublingual Semaglutide 0.5 mL qw x 4w , and if not effective, increase dose to 1 mL qw x 4w, and so on
